Maravai Lifesciences Holdings (MRVI) Deferred Taxes (2020 - 2024)

Maravai Lifesciences Holdings' Deferred Taxes history runs 5 years deep, the most recent figure standing at $11000.0 for Q4 2024.

• In Q4 2024, Deferred Taxes fell 100.0% year-over-year to $11000.0; the TTM figure through Dec 2024 stood at $11000.0 (down 100.0% YoY), while the FY2025 annual figure was -$20000.0, down 281.82% from the prior year.
• Deferred Taxes was $11000.0 for Q4 2024 at Maravai Lifesciences Holdings, down from $764.8 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $764.8 million in Q4 2023 to a low of -$5.5 million in Q3 2023.
• Historically, Deferred Taxes has averaged $52.4 million across 5 years, with a median of $6.7 million in 2021.
• The sharpest annual moves came in 2021 and 2023: Deferred Taxes surged 1122800.0% in 2021, then tumbled 159.91% in 2023.
• A 5-year view of Deferred Taxes shows it stood at -$4.2 million in 2020, then surged by 516.95% to $17.5 million in 2021, then plunged by 59.86% to $7.0 million in 2022, then soared by 10807.86% to $764.8 million in 2023, then plunged by 100.0% to $11000.0 in 2024.
• The last three Deferred Taxes figures came in at $11000.0 (Q4 2024), $764.8 million (Q4 2023), and -$5.5 million (Q3 2023), per Business Quant data.